These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Transintestinal elimination of ciprofloxacin. Rohwedder RW, Bergan T, Thorsteinsson SB, Scholl H. Diagn Microbiol Infect Dis; 1990 Sep; 13(2):127-33. PubMed ID: 2369809 [Abstract] [Full Text] [Related]
27. The effect of Prussian blue and sodium-ethylenediaminetetraacetic acid on the faecal and urinary elimination of thallium by the dog. van der Stock J, de Schepper J. Res Vet Sci; 1978 Nov; 25(3):337-42. PubMed ID: 107548 [Abstract] [Full Text] [Related]
28. Transintestinal elimination of ciprofloxacin. Rohwedder R, Bergan T, Thorsteinsson SB, Scholl H. Chemotherapy; 1990 Nov; 36(2):77-84. PubMed ID: 2311444 [Abstract] [Full Text] [Related]
29. Elimination of tritiated gentamicin in normal human subjects and in patients with severely impaired renal function. Wilson TW, Mahon WA, Inaba T, Johnson GE, Kadar D. Clin Pharmacol Ther; 1973 Nov; 14(5):815-22. PubMed ID: 4729899 [No Abstract] [Full Text] [Related]
31. Prediction of drug dosage in patients with renal failure using data derived from normal subjects. Welling PG, Craig WA, Kunin CM. Clin Pharmacol Ther; 1975 Jul; 18(1):45-52. PubMed ID: 1149361 [Abstract] [Full Text] [Related]
32. Pharmacokinetics and disposition of the lipid-lowering drug acifran in normal subjects and in patients with renal failure. Cayen MN, Ferdinandi ES, Hicks DR, Gonzalez R, Cosyns L, Dubuc J, Kraml M, Edwards KD. Clin Pharmacol Ther; 1990 Jan; 47(1):50-6. PubMed ID: 2295219 [Abstract] [Full Text] [Related]
33. The excretion of metabolites of testosterone and of estradiol in male patients with chronic renal failure. van Kammen E, Thijssen JH, Donker GH, Schwarz F. Steroids; 1975 Oct; 26(4):508-15. PubMed ID: 1202665 [Abstract] [Full Text] [Related]
34. The effect of end-stage renal failure and haemodialysis on the elimination kinetics of sotalol. Tjandramaga TB, Verbeeck R, Thomas J, Verbesselt R, Verberckmoes R, Schepper PJ. Br J Clin Pharmacol; 1976 Apr; 3(2):259-65. PubMed ID: 973960 [Abstract] [Full Text] [Related]
35. Minocycline and doxycycline kinetics in chronic renal failure. Heaney D, Eknoyan G. Clin Pharmacol Ther; 1978 Aug; 24(2):233-9. PubMed ID: 679601 [No Abstract] [Full Text] [Related]
36. [Pharmacokinetics of ethambutol in healthy individuals and in patients with terminal renal failure]. Dume T, Wagner C, Wetzels E. Dtsch Med Wochenschr; 1971 Sep 03; 96(36):1430-4. PubMed ID: 4998424 [No Abstract] [Full Text] [Related]
37. Biotransformation and excretion of lorazepam in patients with chronic renal failure. Verbeeck R, Tjandramaga TB, Verberckmoes R, De Schepper PJ. Br J Clin Pharmacol; 1976 Dec 03; 3(6):1033-9. PubMed ID: 22216526 [Abstract] [Full Text] [Related]
38. [Role of aldosterone in the potassium excretion in patients with advanced chronic renal failure (author's transl)]. Sudo S. Nihon Jinzo Gakkai Shi; 1981 Jun 03; 23(6):825-38. PubMed ID: 7311126 [No Abstract] [Full Text] [Related]
39. The disposition of doxycycline by the rat. Schach VON WITTENAU M, Schachaavonwittenau M, Twomey TM, Swindell AC. Chemotherapy; 1972 Jun 03; 17(1):26-39. PubMed ID: 5009467 [No Abstract] [Full Text] [Related]
40. Pharmacodynamics of propranolol in renal failure. Thompson FD, Joekes AM, Foulkes DM. Br Med J; 1972 May 20; 2(5811):434-6. PubMed ID: 5031656 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]